Arond Tablet (Sodium Alendronate Trihydrate)
Sodium Alendronate Trihydrate 91.37mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.
MFDS item code 201905535 · Approved 2019.08.06
This product's status changed to Expired on 2024.08.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of osteoporosis in postmenopausal women and men
This medication is used for the treatment of osteoporosis in both postmenopausal women and men. Osteoporosis refers to a condition in which bones become weak and are at increased risk of fractures. This drug helps to increase bone density and reduce the risk of fractures. Therefore, it is effective for those whose bones have weakened due to hormonal changes from menopause or aging, and it contributes to the prevention of complications arising from osteoporosis. For these reasons, it is used in the treatment of osteoporosis in both postmenopausal women and men.
○ Take 70 mg of alendronic acid once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages, including mineral water and barley tea, as well as food and medicines, may reduce the absorption of this medicine (see Interactions). Consuming food within 30 minutes after taking this medicine or at the same time may reduce its absorption and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients whose dietary intake of calcium and vitamin D is inadequate should take supplements (see Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be periodically reassessed for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue once weekly thereafter. Do not take 2 tablets on the same day.
This drug, being an oral bisphosphonate, may irritate the mucosa of the upper gastrointestinal tract, so patients with diseases of the esophagus, stomach, or duodenum need to be cautious while taking it. Particularly, serious esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosion may rarely occur, and if symptoms such as difficulty swallowing, pain behind the sternum, or heartburn arise, the medication should be discontinued immediately and a physician consulted. It should be taken in the morning upon waking before meals with plenty of water, and the patient should not lie down for at least 30 minutes after taking it, nor should the tablet be chewed or sucked. Following the proper administration method is crucial to reduce the risk of esophageal irritation, and patients with mental disorders must be guided and supervised prior to taking this medication. This medication should not be administered to patients with certain esophageal diseases, those unable to sit or stand, hypocalcemia patients, severe renal impairment patients, pregnant or nursing women, and patients with genetic lactose-related disorders. During treatment, serum calcium levels should be monitored, and supplementation may be necessary if there is a deficiency in calcium or vitamin D. Adverse reactions may include musculoskeletal pain, gastrointestinal symptoms (abdominal pain, nausea, dyspepsia, etc.), skin rash, headaches, dizziness, taste disturbances, rash, erythema, itching, hair loss, black stools, dizziness, and taste disturbances. Particularly with long-term use, rare occurrences of atypical femoral fractures may arise, so continuous observation is necessary. There are also interactions with other drugs, so calcium supplements or antacids should be taken at least 30 minutes after this medication, and concomitant use with aspirin may increase the risk of gastrointestinal adverse reactions. Pregnant or nursing women should not take this medication, and the safety in children and adolescents under 18 years of age has not been established. Elderly patients may use this medication, but caution is necessary as some may exhibit increased sensitivity. In case of overdose, symptoms may include hypocalcemia and gastrointestinal irritation, and immediate consultation with a medical institution is required. Inducing vomiting should be avoided, and the patient should be kept upright. This drug should be stored out of reach of children and should not be transferred to another container. Patients should be thoroughly instructed on the proper administration and precautions to ensure correct usage.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to protect it from air and moisture, and the temperature should be maintained between 15 to 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness for a longer period.
White oval tablet
4 tablets (4 tablets/PTP packaging (AluAlu)x1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sodium Alendronate Trihydrate 91.37mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Sodium Alendronate 91.37mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Sodium Alendronate 91.37mg
Tablet · Prescription medication
(Co., Ltd.) Jungkundang

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.

Sodium Alendronate Hydrate 91.37mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.